Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions in Gout: A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders; Gout
- Focus Proof of concept; Therapeutic Use
- 27 Sep 2017 Planned End Date changed from 1 Feb 2018 to 1 May 2018.
- 27 Sep 2017 Planned primary completion date changed from 1 Feb 2018 to 1 May 2018.
- 06 Apr 2017 Status changed from not yet recruiting to recruiting.